Gabapentin Tablet, Coated
Product Images NDC 50090-7269

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-7269). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Gabapenin 01)

Chemical Structure (Gabapenin 01)
Chemical structure of Gabapentin showing a cyclohexane ring bonded to an amino group (CH2NH2) and a carboxyl group (CH2CO2H). This structural formula represents the active ingredient Gabapentin.*
FDA Label Image

Figure 1 (Gabapenin 02)

Figure 1 (Gabapenin 02)
A line graph depicting mean pain scores over an 8-week period, comparing a placebo group to a Gabapentin 3,600 mg/day group. The x-axis represents weeks, including a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 9. Gabapentin shows a decreasing trend in pain scores compared to the placebo, which remains relatively constant.*
FDA Label Image

Figure 2 (Gabapenin 03)

Figure 2 (Gabapenin 03)
A line graph showing mean pain scores over 7 weeks including a 3-week dose titration period and a 4-week fixed dose period. It compares placebo with Gabapentin at 1,800 mg/day and 2,400 mg/day, with pain scores decreasing over time for Gabapentin groups compared to placebo.*
FDA Label Image

Figure 3 (Gabapenin 04)

Figure 3 (Gabapenin 04)
A bar chart comparing percentages for placebo (PBO) and gabapentin (GBP) treatments across two studies. Study 1 shows 12% for placebo and 29% for GBP at 3,600 mg. Study 2 shows 14% for placebo and 32% and 34% for GBP at 1,800 mg and 2,400 mg respectively. Statistical significance is indicated for GBP groups.*
FDA Label Image

Figure 4 (Gabapenin 05)

Figure 4 (Gabapenin 05)
A scatter plot showing percentage difference on the Y-axis versus daily dose in milligrams on the X-axis, with data points labeled for three studies (a, b, c) represented by different colored squares. The doses range from 600 mg to 1800 mg.*
FDA Label Image

Label Image (Lbl500907269)

Label Image (Lbl500907269)
Label for Gabapentin 600 mg coated tablets by A-S Medication Solutions. The label states the product NDC 50090-7269-0 and contains 90 tablets. Storage instructions indicate to keep at 77 degrees Fahrenheit. The label includes a QR code and dosage instructions to see the package insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.